136 related articles for article (PubMed ID: 7996395)
1. Pharmacokinetic behaviour in polymorphonuclear leucocytes of N,N-dimethylcarbamoylmethyl alpha,2-dimethyl-5H-[1]benzopyrano[2,3-b]- pyridine-7-acetate (Y-23023), a new prodrug type of anti-inflammatory agent, and indomethacin after oral administrations in rats.
Yamada I; Nagamatsu Y; Imayoshi T; Shibata M; Tsuji A
J Pharm Pharmacol; 1994 Jul; 46(7):614-6. PubMed ID: 7996395
[TBL] [Abstract][Full Text] [Related]
2. Effect of gastric acidity on bioavailability of N,N-dimethylcarbamoylmethylalpha, 2-dimethyl-5H-[1]benzopyrano[2,3-b]pyridine-7-acetate, a new prodrug-type anti-inflammatory agent.
Yamada I; Goda T; Kawata M; Mizuta H; Ogawa K; Yokobe T
Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3372-5. PubMed ID: 2632086
[TBL] [Abstract][Full Text] [Related]
3. [Synthesis, pharmacological activity and biopharmaceutical characteristics of alpha,2-dimethyl-5H-[1]benzopyrano[2,3-b]pyridine-7-acetates].
Kawasaki K; Yamada I; Oe T; Tsuruda M; Terasawa M; Imayoshi T; Yasunaga Y; Goto K
Yakugaku Zasshi; 1989 Nov; 109(11):827-34. PubMed ID: 2614665
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetic and pharmacodynamic profile of the trioxyethylene ester of indomethacin in a new oral prodrug].
Palagiano F; de Caprariis P; Bonina FP; Montenegro L; Capasso A; Sorrentino L
Boll Chim Farm; 1996 Feb; 135(2):89-91. PubMed ID: 9044565
[No Abstract] [Full Text] [Related]
5. Pharmacokinetic evaluation of indomethacin ethyl ester-loaded nanoencapsules.
Cattani VB; Pohlmann AR; Dalla Costa T
Int J Pharm; 2008 Nov; 363(1-2):214-6. PubMed ID: 18678236
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and safety of a novel, long-acting, prodrug-type potassium channel opener, Y-27152, in healthy volunteers.
Uematsu T; Kosuge K; Hirosawa S; Kadobe Y; Hibi T; Nakashima M
J Clin Pharmacol; 1996 May; 36(5):439-51. PubMed ID: 8739023
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of indomethacin ester prodrugs: gastrointestinal and hepatic toxicity and the hydrolytic capacity of various tissues in rats.
Ogiso T; Iwaki M; Tanino T; Nagai T; Ueda Y; Muraoka O; Tanabe G
Biol Pharm Bull; 1996 Sep; 19(9):1178-83. PubMed ID: 8889037
[TBL] [Abstract][Full Text] [Related]
8. Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen-ethylene-vinyl acetate matrix containing penetration enhancer in rats.
Cho CW; Choi JS; Yang KH; Shin SC
Arch Pharm Res; 2009 May; 32(5):747-53. PubMed ID: 19471890
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of indomethacin by iontophoresis.
Kanebako M; Inagi T; Takayama K
Biol Pharm Bull; 2002 Jun; 25(6):779-82. PubMed ID: 12081146
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of indomethacin octyl ester (prodrug) and indomethacin produced from the prodrug.
Ogiso T; Iwaki M; Kinoshita T; Tanino T; Paku T
J Pharm Sci; 1994 Jan; 83(1):34-7. PubMed ID: 8138906
[TBL] [Abstract][Full Text] [Related]
11. [Analgesic and anti-inflammatory effect of (+/-)-N,N- dimethylcarbamoylmethyl 2-[7-(2-methyl-5H-[1] benzopyrano [2,3-b] pyridyl)] propionate (Y-23023), a new non-steroidal anti-inflammatory drug].
Iwahisa Y; Yasunaga Y; Ochi H; Matsuura M; Imayoshi T; Terasawa M
Nihon Yakurigaku Zasshi; 1995 Aug; 106(2):99-111. PubMed ID: 7557742
[TBL] [Abstract][Full Text] [Related]
12. A phase I study evaluating the pharmacokinetic profile of a novel, proprietary, nano-formulated, lower-dose oral indomethacin.
Manvelian G; Daniels S; Altman R
Postgrad Med; 2012 Jul; 124(4):197-205. PubMed ID: 22913908
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of four metabolites of DA-125, a new anthracycline antineoplastic agent after single and multiple intravenous administration to rats.
Lee SD; Lee WI; Shim HJ; Lee ED; Kim WB; Yang J; Kim CK; Lee MG
J Clin Pharm Ther; 1996 Aug; 21(4):201-13. PubMed ID: 8933293
[TBL] [Abstract][Full Text] [Related]
14. Enhanced absorption of indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats.
Kim JY; Ku YS
Int J Pharm; 2000 Jan; 194(1):81-9. PubMed ID: 10601687
[TBL] [Abstract][Full Text] [Related]
15. [Dissolution properties and bioavailability of ground mixture of N,N-dimethylcarbamoylmethyl alpha, 2-dimethyl-5H-[1]benzopyrano[2,3-b]-pyridine-7-acetate with various pharmaceutical ingredients].
Yamada I; Kawata M; Shibata T; Ogawa K; Yokobe T
Yakugaku Zasshi; 1989 Dec; 109(12):932-7. PubMed ID: 2630636
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of the amino acid-attached prodrug as a new anti-HIV agent in rats.
Chae KA; Cho HJ; Sung JM; Lee H; Seo DC; Kim JS; Shin HC
J Vet Sci; 2007 Sep; 8(3):263-7. PubMed ID: 17679773
[TBL] [Abstract][Full Text] [Related]
17. A comparative bioavailability study to estimate the influence of an antacid on droxicam pharmacokinetics.
Maya MT; Pais JP; Ruas Da Silva J; Morais JA
Eur J Drug Metab Pharmacokinet; 1995; 20(4):275-9. PubMed ID: 8983932
[TBL] [Abstract][Full Text] [Related]
18. Effect of food on systemic exposure to niflumic acid following postprandial administration of talniflumate.
Kang W; Kim K; Kim EY; Kwon KI; Bang JS; Yoon YR
Eur J Clin Pharmacol; 2008 Oct; 64(10):1027-30. PubMed ID: 18607579
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological studies of 2-(5H-(1)benzopyrano[2,3-b]pyridin-7-yl)propionic acid (Y-8004). (3) Its interaction with anti-inflammatory agents].
Maruyama Y; Imayoshi T; Foto K; Kadobe Y
Nihon Yakurigaku Zasshi; 1977 Jan; 73(1):113-22. PubMed ID: 558941
[TBL] [Abstract][Full Text] [Related]
20. Plasma and cerebrospinal fluid concentrations of indomethacin in children after intravenous administration.
Mannila A; Kumpulainen E; Lehtonen M; Heikkinen M; Laisalmi M; Salo T; Rautio J; Savolainen J; Kokki H
J Clin Pharmacol; 2007 Jan; 47(1):94-100. PubMed ID: 17192507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
